«By 2010, the company launched the first generation of its Zio platform for cardiac monitoring. While Day said it was effective, it remained that it was “very much” a first-generation offering with plenty of room to grow. These days, iRhythm is challenging the traditional Holder monitor with its next-gen Zio XT with a new and improved design of its flagship wearable Zio monitor and updated artificial intelligence (AI) capabilities. FDA cleared the changes in May.»

Article written by  Sean Whooley. Photo by iRhythm.



Medical Design&Outsourcing